The chemotherapy induced neutropenia (CIN) market is estimated to be valued at USD 14.88 Bn in 2025 and is expected to reach USD 21.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032. https://timessquarereporter.com/news/chemotherapy-induced-neutropenia-market-to-see-high-growth-from-pegylated-g-csf-agents